Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Primary Brain Cancer
2.
Drug Delivery Global Industry Guide
3.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
4.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
5.
BioNewsCast Press Release Distribution Service
6.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
7.
Cell Therapy - Technologies, Markets and Companies
8.
Cytogenetics - technologies, markets and companies
9.
Molecular Diagnostics Markets
10.
The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
Drug Delivery Series I-IV
This report includes all four volumes of Kalorama's 2nd edition of its Drug Delivery Markets series, covering all major types, including:
Oral Delivery
Implantable/Injectable
Pulmonary
Transdermal/Transmucosal
Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. While oral delivery remains the most popular and cost-effective methods, implantable and injectable and pulmonary methods are options for fast distribution and stronger dosage. Transdermal patches and new electric transfers allow painless entry for medicines that cannot be administered orally.
Kalorama's Drug Delivery Markets series provides exhaustive coverage of four key areas of drug delivery.
As part of Kalorama's trusted information-gathering process, over 70 industry executives in the drug delivery area were interviewed, along with through research of public information, medical journals and company reports. Interviews provide the basis of forecasts.
Apr 1, 2007
475 Pages
PDF Format
Table of Contents
Price: $6,995.00 / GBP3,497.50
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.